National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia

Authors

  • Justin Waring Western Australian TB Control Program Government of Western Australian Department of Health
  • National Tuberculosis Advisory Committee

DOI:

https://doi.org/10.33321/cdi.2017.41.28

Keywords:

tuberculosis, healthcare workers

Abstract

Tuberculosis (TB) is uncommon in Australia and not commonly managed by most healthcare workers (HCWs). However, even in a low incidence setting, occasional exposure of HCWs is inevitable and transmission of TB to HCWs leading to disease does occur. In addition, HCWs may have been recruited to Australia from countries with high TB incidence. These HCWs are more likely to be infected with TB before arrival and subsequently develop active disease while working in health settings in Australia. In 2001, there were 20 TB notifications in HCWs in Australia, of which 10 were born overseas, whereas in 2013, 70 of 77 notified cases (91%) were people born overseas.1, 2 Managing the risk of TB in HCWs is multifaceted. A combination of staff education, awareness, early diagnosis, appropriate use of personal protective equipment (PPE), environmental controls and screening procedures is required to minimise the risk of transmission to HCWs and from HCWs to patients. Prevention of nosocomial transmission from HCWs is particularly important in patients that are more vulnerable, for example children and the immunocompromised. This document aims to describe the components that are considered essential for all healthcare facilities in Australia to minimise this risk. It is not intended to be operational, and reference should be made to specific state and territory TB Control Program policies for this detail. Each facility should develop its own policy for the management of TB risk in HCWs according to this jurisdictional policy and the facility specific factors that determine risk, but it should include at least the following components.

Downloads

Download data is not yet available.

References

Toms C, Stapledon R, Waring J, Douglas P, National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia, and the Australian Mycobacterium Reference Laboratory Network. Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell. 2015;39(2).

Barry C, Konstantinos A, National Tuberculosis Advisory Committee. Tuberculosis notifications in Australia, 2007. Commun Dis Intell. 2009;33(3):304-15.

Alexander TS, Miller MB, Gilligan P. Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States? J Clin Microbiol. 2011;49(6):2086-92. Epub 2011/04/08.

Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3-20. Epub 2014/01/08.

Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J. 2012;19(2):84-8. Epub 2012/04/27.

National Tuberculosis Advisory Committee. Position statement on interferon-gamma release assays in the detection of latent tuberculosis infection. Commun Dis Intell. 2012;36(1):125-31. Epub 2012/11/17.

Communicable Disease Network Australia. Tuberculosis: CDNA National Guidelines for the Public Health Management of TB. 2013 [4 November 2015]; Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/D140EDF48C0A0CEACA257BF0001A3537/$File/TB-2.0-april2015.pdf.

National Tuberculosis Advisory Committee. The BCG vaccine: Information and recommendations for use in Austalia. Commun Dis Intell. 2013;37(1):E65-E72.

Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th ed. Canberra, Australia: National Health and Medical Research Council and the Department of Health; 2013 (updated January 2014).

Coulter C, National Tuberculosis Advisory Committee. Infection Control Guidelines for the Management of Patients with Suspected or Confirmed Pulmonary Tuberculosis in Healthcare Settings. Commun Dis Intell. 2016;40(3):E360-E366.

National Tuberculosis Advisory Committee. Guidelines for Australian Mycobacteriology Laboratories. Commun Dis Intell. 2006;30(1):116-28.

Downloads

Published

01/09/17

How to Cite

Waring, Justin, and National Tuberculosis Advisory Committee. 2017. “National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia”. Communicable Diseases Intelligence 41 (September):119-203. https://doi.org/10.33321/cdi.2017.41.28.

Issue

Section

Policy and guidelines

Categories